65 related articles for article (PubMed ID: 10623568)
1. A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Trieu VN; Liu R; Liu XP; Uckun FM
Biochem Biophys Res Commun; 2000 Jan; 267(1):22-5. PubMed ID: 10623568
[TBL] [Abstract][Full Text] [Related]
2. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke.
Trieu VN; Uckun FM
Biochem Biophys Res Commun; 1999 May; 258(3):685-8. PubMed ID: 10329446
[TBL] [Abstract][Full Text] [Related]
3. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
6. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
[TBL] [Abstract][Full Text] [Related]
7. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
[TBL] [Abstract][Full Text] [Related]
8. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Dalle-Donne I
Free Radic Biol Med; 2007 Jul; 43(2):157-9. PubMed ID: 17603924
[No Abstract] [Full Text] [Related]
9. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Calabrese V
Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
[TBL] [Abstract][Full Text] [Related]
11. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
12. Mutant CuZn superoxide dismutase in motor neuron disease.
Gurney ME; Liu R; Althaus JS; Hall ED; Becker DA
J Inherit Metab Dis; 1998 Aug; 21(5):587-97. PubMed ID: 9728338
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
15. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
[TBL] [Abstract][Full Text] [Related]
16. Prevention of islet allograft rejection in diabetic mice by targeting Janus Kinase 3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (JANEX-1).
Cetkovic-Cvrlje M; Dragt AL; Uckun FM
Arzneimittelforschung; 2003; 53(9):648-54. PubMed ID: 14558439
[TBL] [Abstract][Full Text] [Related]
17. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
18. The specificity of JAK3 kinase inhibitors.
Changelian PS; Moshinsky D; Kuhn CF; Flanagan ME; Munchhof MJ; Harris TM; Whipple DA; Doty JL; Sun J; Kent CR; Magnuson KS; Perregaux DG; Sawyer PS; Kudlacz EM
Blood; 2008 Feb; 111(4):2155-7. PubMed ID: 18094329
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanisms of amyotrophic lateral sclerosis: recent contributions from studies in animal models].
Dupuis L; Muller A; Meininger V; Loeffler JP
Rev Neurol (Paris); 2004 Jan; 160(1):35-43. PubMed ID: 14978392
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis.
Upton-Rice MN; Cudkowicz ME; Warren L; Mathew RK; Ren JM; Finklestein SP; Brown RH
Ann Neurol; 1999 Dec; 46(6):934. PubMed ID: 10589551
[No Abstract] [Full Text] [Related]
[Next] [New Search]